Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$657 Sell
35
-1,730
-98% -$39.6K ﹤0.01% 547
2022
Q1
$64K Sell
1,765
-262
-13% -$7.88K 0.02% 540
2021
Q4
$62.2K Sell
2,027
-588
-22% -$23.9K 0.02% 476
2021
Q3
$178K Sell
2,615
-504
-16% -$41K 0.04% 423
2021
Q2
$264K Buy
3,119
+140
+5% +$11.6K 0.06% 323
2021
Q1
$255K Buy
+2,979
New +$284K 0.07% 260

Other funds holding CHGG

Exane Derivatives's CHGG Position: Q2 2022 in Review

Exane Derivatives reduced its Chegg (CHGG) stake by 98% in Q2 2022, selling an estimated $39.6K and leaving 35 shares worth $657. The position accounts for ﹤0.01% of the portfolio, ranked #547.

Exane Derivatives first reported a position in CHGG in Q1 2021 and has held it in 6 quarters since. The position peaked at $264K in Q2 2021. 279 funds tracked by Wall St. Rank hold CHGG as of Q2 2022.

  • Exane Derivatives held 35 shares of Chegg worth $657 as of Q2 2022.
  • Exane Derivatives sold 1,730 Chegg shares in Q2 2022, an estimated $39.6K.
  • Chegg made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #547 holding.
  • Exane Derivatives first reported a position in Chegg in Q1 2021 and has held it in 6 quarters since.
  • Exane Derivatives's Chegg position peaked at $264K in Q2 2021.
  • 279 funds tracked by Wall St. Rank held Chegg as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.